Quality and applicability assessment for systematic reviews on acupuncture treatment for primary depression_Chinese Journal of Evidence-Based Medicine

Authors：

XU Guixing , LI Juan , YIN Zihan , LI Yuxi , FU Yanan , ZHOU Jun ,  LIANG Fanrong

Chengdu University of Traditional Chinese Medicine, Chengdu 610041, P.R.China;

Corresponding author：

LIANG Fanrong, Email: acuresearch@126.com

Keywords：

Primary depression; Acupuncture; Review of systematic reviews; Assessment of multiple systematic reviews (AMSTAR); Risk of bias in systematic review (ROBIS); Critical appraisal skill program in systematic review (CASP-S.R)

DOI：

10.7507/1672-2531.201903092

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objectives To comprehensively evaluate the methodological quality and applicability of the results of systematic reviews on acupuncture treatment for primary depression.Methods Web of Science, EMbase, PubMed, The Cochrane Library, CNKI, CBM, WanFang Data and VIP databases were electronically searched to collect systematic reviews/meta-analyses on acupuncture treatment for primary depression from inception to December 5^th, 2018. Two researchers independently screened and extracted data by using tools of AMSTAR 2 to evaluate the methodological quality, using ROBIS to assess risk of bias, and using CASP-S.R to evaluate the applicability of the results.Results A total of 18 systematic reviews/meta-analyses were included, and all focused on acupuncture intervention, including 2 primary outcome indicators. According to AMSTAR 2 evaluation results, there were 4 high quality studies, 12 medium quality studies and 2 low quality studies; ROBIS results found 10 high bias risk studies, 7 low bias risk studies and 1 unclear; CASP-S.R showed only 4 design studies applicable to local individuals, and there were no studies on the relationship between design benefits, hazards and costs.Conclusions The quality of systematic reviews/meta-analyses for acupuncture treatment of primary depression is moderate, however with a certain bias. Most studies may not directly benefit local individuals. All studies have no relationship with cost hazards. It is expected for further reviewers to strictly follow systematic evaluation method to improve research quality and reduce bias, while the applicability of the systematic review to individuals from different regions should be considered as well as the relationship between the benefit and cost hazard. In addition, more valid RCTs are required to provide higher quality evidence and explore correlated and comprehensive mechanism.

Citation： XU Guixing, LI Juan, YIN Zihan, LI Yuxi, FU Yanan, ZHOU Jun, LIANG Fanrong. Quality and applicability assessment for systematic reviews on acupuncture treatment for primary depression. Chinese Journal of Evidence-Based Medicine, 2019, 19(11): 1333-1340. doi: 10.7507/1672-2531.201903092 Copy

1.	中华医学会精神科分会. 中国精神障碍分类与诊断标准 (第 3 版). 济南: 山东科学技术出版社, 2001.
2.	Holden C. Mental health. Global survey examines impact of depression. Science, 2000, 288(5463): 39-40.
3.	Murray CJ, Lopez AD. Evidence-based health policy-lessons from the Global Burden of Disease Study. Science, 1996, 274(5288): 740-743.
4.	范毅. 选择性 5-羟色胺再摄取抑制剂类药物的研究进展. 药物评价研究, 2012, 35(2): 126-129.
5.	Metternich B, Kosch D, Kriston L, et al. The effects of nonpharmacological interventions on subjective memory complaints: a systematic review and meta-analysis. Psychother Psychosom, 2010, 79(1): 6-19.
6.	Marcus D. Managing headache during pregnancy and lactation. Expert Rev Neurother, 2008, 8(3): 385-395.6.
7.	张俊华, 商洪才, 张伯礼. 系统评价和 Meta 分析质量的评价方法. 中西医结合学报, 2008, 6(4): 337-340.7.
8.	曾宪涛, 黄伟, 田国祥. Meta 分析系列之九: Meta 分析的质量评价工具. 中国循证心血管医学杂志, 2013, 5(1): 3-5.8.
9.	Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol, 2007, 7: 10.
10.	陶欢, 杨乐天, 平安, 等. 随机或非随机防治性研究系统评价的质量评价工具 AMSTAR 2 解读. 中国循证医学杂志, 2018, 18(1): 101-108.
11.	丁泓帆, 吴琼芳, 杨楠, 等. 评估系统评价偏倚风险的 ROBISIS 工具实例解读. 中国循证医学杂志, 2016, 16(01): 115-121.
12.	吴琼芳, 丁泓帆, 邓围, 等. ROBIS: 评估系统评价偏倚风险的新工具. 中国循证医学杂志, 2015, 15(12): 1454-1457.
13.	高木健, 赵雪, 陈波, 等. 基于 GRADE 系统的针灸治疗抑郁症随机对照试验临床证据的评价研究. 中国针灸学会刺络与拔罐专业委员会第二届学术交流大会论文集. 2012: 118-122.
14.	樊凌. 针灸治疗抑郁症的文献评价和临床研究. 广州: 广州中医药大学, 2011.
15.	张迪. 针刺治疗抑郁失眠共病随机对照试验的系统评价. 黑龙江中医药大学, 2017.
16.	王珑, 孙冬玮, 邹伟, 等. 针刺治疗抑郁症疗效与安全性的系统评价. 中国针灸, 2008, 28(5): 381-386.
17.	Nguyen BQ, Nghiem HT, Ngo QH, et al. 针灸与五羟色胺再摄取抑制剂 (SSRI) 类药物改善抑郁症患者生活质量的 Meta 分析. 世界最新医学信息文摘, 2017, 17(99): 120-124.
18.	宋洪涛, 武忠, 张瑞霞. 针刺督脉穴位治疗抑郁症的 Meta 分析. 国际医药卫生导报, 2017, 23(2): 250-253.
19.	沈慧, 张捷, 杨婧, 等. 针刺治疗抑郁症随机对照研究的系统评价. 新中医, 2014, 46(6): 220-222.
20.	黎波, 杜元灏, 王栩, 等. 针刺治疗原发性抑郁症干预方式研究: Meta 分析与层次分析法. 中国针灸, 2013, (5): 463-467.
21.	边兴坤, 傅立新, 左小宏, 等. 针刺与药物治疗抑郁症疗效比较的系统评价. 针灸临床杂志, 2011, 27(8): 59-62.
22.	熊俊, 杜元灏, 刘佳琳, 等. 针灸与西药治疗抑郁性神经症疗效比较的系统评价. 中国循证医学杂志, 2009, 9(9): 969-975.
23.	钟宝亮, 黄悦勤, 李会娟. 针灸治疗抑郁症疗效和安全性的系统评价. 中国心理卫生杂志, 2008, 22(9): 641-647.
24.	孙燕丽, 陈爽白, 高轶, 等. 国内针刺与西药治疗抑郁症疗效比较的系统评价. 中国循证医学杂志, 2008, 8(5): 340-345.
25.	Dong B, Chen Z, Yin X, et al. The efficacy of acupuncture for treating depression-related insomnia compared with a control group: a systematic review and meta-analysis. Biomed Res Int, 2017: 9614810.
26.	Chan YY, Lo WY, Yang SN, et al. The benefit of combined acupuncture and antidepressant medication for depression: A systematic review and meta-analysis. J Affect Disord, 2015, 176: 106-117.
27.	Fan L, Fu W, Xu N, et al. Meta-analysis of 20 clinical, randomized, controlled trials of acupuncture for depression. Neural Regen Res, 2010, 5(24): 1862-1869.
28.	Wang H, Qi H, Wang BS, et al. Is acupuncture beneficial in depression: a meta-analysis of 8 randomized controlled trials? J Affect Disord, 2008, 111(2-3): 125-134.
29.	Mukaino Y, Park J, White A, et al. The effectiveness of acupuncture for depression--a systematic review of randomised controlled trials. Acupunct Med, 2005, 23(2): 70-76.
30.	Zhang ZJ, Chen HY, Yip KC, et al. The effectiveness and safety of acupuncture therapy in depressive disorders: systematic review and meta-analysis. J Affect Disord, 2010, 124(1-2): 9-21.

1. 中华医学会精神科分会. 中国精神障碍分类与诊断标准 (第 3 版). 济南: 山东科学技术出版社, 2001.
2. Holden C. Mental health. Global survey examines impact of depression. Science, 2000, 288(5463): 39-40.
3. Murray CJ, Lopez AD. Evidence-based health policy-lessons from the Global Burden of Disease Study. Science, 1996, 274(5288): 740-743.
4. 范毅. 选择性 5-羟色胺再摄取抑制剂类药物的研究进展. 药物评价研究, 2012, 35(2): 126-129.
5. Metternich B, Kosch D, Kriston L, et al. The effects of nonpharmacological interventions on subjective memory complaints: a systematic review and meta-analysis. Psychother Psychosom, 2010, 79(1): 6-19.
6. Marcus D. Managing headache during pregnancy and lactation. Expert Rev Neurother, 2008, 8(3): 385-395.6.
7. 张俊华, 商洪才, 张伯礼. 系统评价和 Meta 分析质量的评价方法. 中西医结合学报, 2008, 6(4): 337-340.7.
8. 曾宪涛, 黄伟, 田国祥. Meta 分析系列之九: Meta 分析的质量评价工具. 中国循证心血管医学杂志, 2013, 5(1): 3-5.8.
9. Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol, 2007, 7: 10.
10. 陶欢, 杨乐天, 平安, 等. 随机或非随机防治性研究系统评价的质量评价工具 AMSTAR 2 解读. 中国循证医学杂志, 2018, 18(1): 101-108.
11. 丁泓帆, 吴琼芳, 杨楠, 等. 评估系统评价偏倚风险的 ROBISIS 工具实例解读. 中国循证医学杂志, 2016, 16(01): 115-121.
12. 吴琼芳, 丁泓帆, 邓围, 等. ROBIS: 评估系统评价偏倚风险的新工具. 中国循证医学杂志, 2015, 15(12): 1454-1457.
13. 高木健, 赵雪, 陈波, 等. 基于 GRADE 系统的针灸治疗抑郁症随机对照试验临床证据的评价研究. 中国针灸学会刺络与拔罐专业委员会第二届学术交流大会论文集. 2012: 118-122.
14. 樊凌. 针灸治疗抑郁症的文献评价和临床研究. 广州: 广州中医药大学, 2011.
15. 张迪. 针刺治疗抑郁失眠共病随机对照试验的系统评价. 黑龙江中医药大学, 2017.
16. 王珑, 孙冬玮, 邹伟, 等. 针刺治疗抑郁症疗效与安全性的系统评价. 中国针灸, 2008, 28(5): 381-386.
17. Nguyen BQ, Nghiem HT, Ngo QH, et al. 针灸与五羟色胺再摄取抑制剂 (SSRI) 类药物改善抑郁症患者生活质量的 Meta 分析. 世界最新医学信息文摘, 2017, 17(99): 120-124.
18. 宋洪涛, 武忠, 张瑞霞. 针刺督脉穴位治疗抑郁症的 Meta 分析. 国际医药卫生导报, 2017, 23(2): 250-253.
19. 沈慧, 张捷, 杨婧, 等. 针刺治疗抑郁症随机对照研究的系统评价. 新中医, 2014, 46(6): 220-222.
20. 黎波, 杜元灏, 王栩, 等. 针刺治疗原发性抑郁症干预方式研究: Meta 分析与层次分析法. 中国针灸, 2013, (5): 463-467.
21. 边兴坤, 傅立新, 左小宏, 等. 针刺与药物治疗抑郁症疗效比较的系统评价. 针灸临床杂志, 2011, 27(8): 59-62.
22. 熊俊, 杜元灏, 刘佳琳, 等. 针灸与西药治疗抑郁性神经症疗效比较的系统评价. 中国循证医学杂志, 2009, 9(9): 969-975.
23. 钟宝亮, 黄悦勤, 李会娟. 针灸治疗抑郁症疗效和安全性的系统评价. 中国心理卫生杂志, 2008, 22(9): 641-647.
24. 孙燕丽, 陈爽白, 高轶, 等. 国内针刺与西药治疗抑郁症疗效比较的系统评价. 中国循证医学杂志, 2008, 8(5): 340-345.
25. Dong B, Chen Z, Yin X, et al. The efficacy of acupuncture for treating depression-related insomnia compared with a control group: a systematic review and meta-analysis. Biomed Res Int, 2017: 9614810.
26. Chan YY, Lo WY, Yang SN, et al. The benefit of combined acupuncture and antidepressant medication for depression: A systematic review and meta-analysis. J Affect Disord, 2015, 176: 106-117.
27. Fan L, Fu W, Xu N, et al. Meta-analysis of 20 clinical, randomized, controlled trials of acupuncture for depression. Neural Regen Res, 2010, 5(24): 1862-1869.
28. Wang H, Qi H, Wang BS, et al. Is acupuncture beneficial in depression: a meta-analysis of 8 randomized controlled trials? J Affect Disord, 2008, 111(2-3): 125-134.
29. Mukaino Y, Park J, White A, et al. The effectiveness of acupuncture for depression--a systematic review of randomised controlled trials. Acupunct Med, 2005, 23(2): 70-76.
30. Zhang ZJ, Chen HY, Yip KC, et al. The effectiveness and safety of acupuncture therapy in depressive disorders: systematic review and meta-analysis. J Affect Disord, 2010, 124(1-2): 9-21.

Chinese Journal of Evidence-Based Medicine

Quality and applicability assessment for systematic reviews on acupuncture treatment for primary depression

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content